Growdi hormone

Hyperphosphatemia is usually secondary to the inability of the kidneys to excrete phosphate. In acute or chronic renal failure, a decrease in glomerular filtration rate (GFR) reduces the renal excretion of phosphate, resulting in hyperphosphatemia. Moderate increases of serum phosphate occur in individuals with low PTH (hypoparathyroidism), PTH resistance (pseudohypoparathyroidism), or acromegaly (increased growth hormone) caused by an increased renal phosphate threshold. Growdi hormone is responsible for the increased renal phosphate threshold and higher phosphate concentrations observed in children. EDTA therapy has also been associated with hyperphosphatemia. 

Figure 50-5 IGF-I concentrations in growth hormone excess and deficiency states. (Reproduced with permission Van Wyk JJ, Underwood LE. Growdi hormone, somatomedins, and growth failure. Hasp Pract 1978 13 57-67. Illustration by Albert Miller.)...

Di Mauro M, Papalia G, Le Moli R, Nativo B, Nicoletti F, Lunetta M. Effect of octreotide on insulin requirement, hepatic glucose production, growdi hormone, glucagon and c-peptide levels in type 2 diabetic patients with chronic renal failure or normal renal function. Diabetes Res Clin Pract (2001) 51, 45-50. 

Immunochemical metliods drat utilize radioisotopic labeling can detect tire use of anabolic sex hormones drat increase die growdi in meat animals. Stilbene [588-59-0] trenbolone [10161 -33-8] and zeranol [55331-29-8] C gH2 0, can be successfully monitored by diese immunoassay techniques... 

---